✦ LIBER ✦

751e Adalimumab Induces and Maintains Mucosal Healing in Patients with Moderate to Severe Ileocolonic Crohn's Disease – First Results of the Extend Trial

✍ Scribed by Paul Rutgeerts; Geert R. D'Haens; Gert A. Van Assche; William J. Sandborn; Douglas C. Wolf; Jean-Frederic Colombel; Walter Reinisch; Karel Geboes; Mahmudul Khan; Andreas Lazar; Anne Camez; Paul F. Pollack

Book ID: 119430377
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 145 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(09)60520-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab Induces and Maintains Clinica

Adalimumab Induces and Maintains Clinical Response and Remission in Patients With Active Crohn’s Disease: Results of the CHARM Trial

✍ J. Colombel; W.J. Sandborn; P. Rutgeerts; R. Enns; S.B. Hanauer; P. Remo; S. Sch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Adalimumab improves patient-reported out

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial

✍ Louis, Edouard; Löfberg, Robert; Reinisch, Walter; Camez, Anne; Yang, Mei; Polla 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 448 KB

P302 The impact of induction and mainten

P302 The impact of induction and maintenance therapy with infliximab on mucosal healing and clinical remission in Polish pediatric patients with moderate to severe Crohn's disease

✍ J. Kierkus; E. Szymanska; M. Dadalski; A. Wegner; G. Oracz; M. Gorczewska; S. Sz 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB